Your browser doesn't support javascript.
loading
Cardiac safety of dual anti-HER2 blockade with pertuzumab plus trastuzumab in early HER2-positive breast cancer in the APHINITY trial.
de Azambuja, E; Agostinetto, E; Procter, M; Eiger, D; Pondé, N; Guillaume, S; Parlier, D; Lambertini, M; Desmet, A; Caballero, C; Aguila, C; Jerusalem, G; Walshe, J M; Frank, E; Bines, J; Loibl, S; Piccart-Gebhart, M; Ewer, M S; Dent, S; Plummer, C; Suter, T.
Afiliação
  • de Azambuja E; Institut Jules Bordet and L'Université Libre de Bruxelles (U.L.B), Brussels, Belgium. Electronic address: evandro.azambuja@bordet.be.
  • Agostinetto E; Institut Jules Bordet and L'Université Libre de Bruxelles (U.L.B), Brussels, Belgium.
  • Procter M; Frontier Science, Kincraig, Kingussie, UK.
  • Eiger D; F.Hoffmann-La Roche Ltd, Basel, Switzerland.
  • Pondé N; Clinical Oncology Department, AC Camargo Cancer Center, São Paulo, Brazil.
  • Guillaume S; Institut Jules Bordet and L'Université Libre de Bruxelles (U.L.B), Brussels, Belgium.
  • Parlier D; Institut Jules Bordet and L'Université Libre de Bruxelles (U.L.B), Brussels, Belgium.
  • Lambertini M; Department of Medical Oncology, U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy; Department of Internal Medicine and Medical Sciences (DiMI), School of Medicine, University of Genova, Genova, Italy.
  • Desmet A; Institut Jules Bordet and L'Université Libre de Bruxelles (U.L.B), Brussels, Belgium.
  • Caballero C; Breast International Group, Brussels, Belgium.
  • Aguila C; F.Hoffmann-La Roche Ltd, Basel, Switzerland.
  • Jerusalem G; CHU Liege and Liege University, Liege, Belgium.
  • Walshe JM; Cancer Trials Ireland, St Vincent's University Hospital, Dublin, Ireland.
  • Frank E; Dana-Farber Cancer Institute, Boston, USA.
  • Bines J; Instituto Nacional de Cancer, INCA, Rio de Janeiro, Brazil.
  • Loibl S; German Breast Group, Neu-Isenburg, Germany.
  • Piccart-Gebhart M; Institut Jules Bordet and L'Université Libre de Bruxelles (U.L.B), Brussels, Belgium.
  • Ewer MS; University of Texas, MD Anderson Cancer Center, Houston.
  • Dent S; Duke Cancer Institute, Duke University, Durham, USA.
  • Plummer C; Department of Cardiology, Freeman Hospital, Newcastle upon Tyne, UK.
  • Suter T; Department of Cardiology, Cardio-Oncology, Bern University Hospital, Bern, Switzerland.
ESMO Open ; 8(1): 100772, 2023 02.
Article em En | MEDLINE | ID: mdl-36681013
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Risk_factors_studies Limite: Aged / Female / Humans Idioma: En Revista: ESMO Open Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Risk_factors_studies Limite: Aged / Female / Humans Idioma: En Revista: ESMO Open Ano de publicação: 2023 Tipo de documento: Article